The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Changes In Market Value Are Expected For The Transcatheter Mitral Valve Market Over The 2026–2030 Period?
The transcatheter mitral valve market size has experienced robust growth over recent years. It is anticipated to expand from $1.61 billion in 2025 to $1.76 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.3%. This historical growth can be linked to factors such as the restricted initial availability of transcatheter mitral valves, the widespread reliance on surgical valve replacement, rising awareness concerning mitral valve disease, an increase in hospital cardiac procedures, and the early adoption of these devices in patient groups at high risk.
The transcatheter mitral valve market is projected to experience substantial expansion in the coming years, with its size set to reach $2.49 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.0%. This projected growth is driven by factors such as advancements in transcatheter valve technologies, an increasing elderly demographic suffering from mitral valve conditions, the proliferation of cardiac catheterization facilities, escalating healthcare spending, and the uptake of minimally invasive cardiac intervention methods. Key trends anticipated during this period encompass the increasing preference for minimally invasive cardiac surgeries, the wider deployment of self-expanding and balloon-expandable valve technologies, the broadening availability of edge-to-edge and chordal repair solutions, a higher incidence of mitral valve diseases among older individuals, and the incorporation of imaging and navigation systems to enhance procedural precision.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/report/transcatheter-mitral-valve-global-market-report
What Major Factors Are Driving The Transcatheter Mitral Valve Market Forward?
The anticipated expansion of the transcatheter mitral valve market is linked to the rising occurrence of heart diseases. These conditions involve disruptions to the heart’s structure or function, impairing its blood-pumping efficacy. The increasing incidence of heart diseases stems from aging demographics, where age-related degradation of the heart and blood vessels heightens susceptibility to ailments like mitral valve regurgitation, heart failure, and arrhythmias. Transcatheter mitral valves provide a therapeutic solution for heart disease by repairing or substituting a compromised mitral valve, thereby re-establishing proper blood flow between heart chambers, enhancing cardiac function, and alleviating symptoms. As an illustration, data from August 2025, released by the National Center for Biotechnology Information, a US governmental agency, forecasts a substantial surge in cardiovascular disease between 2025 and 2050. This includes a 90.0% rise in prevalence, a 73.4% increase in crude mortality, and a 54.7% growth in crude DALYs, culminating in an estimated 35.6 million cardiovascular deaths in 2050, compared to 20.5 million in 2025. Consequently, the escalating frequency of heart diseases is a primary catalyst for the expansion of the transcatheter mitral valve market.
Which Segment Classifications Are Used In The Transcatheter Mitral Valve Market Segment Analysis?
The transcatheter mitral valve market covered in this report is segmented –
1) By Product: Transcatheter Mitral Valve Replacement, Transcatheter Mitral Valve Repair
2) By Indication: Mitral Stenosis, Mitral Regurgitation
3) By End-User: Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Laboratories
Subsegments:
1) By Transcatheter Mitral Valve Replacement: Self-Expanding Valves, Balloon-Expandable Valves
2) By Transcatheter Mitral Valve Repair: Annuloplasty Devices, Chordal Repair Devices, Edge-To-Edge Repair Devices
Which Trends Are Impacting The Progress Of The Transcatheter Mitral Valve Market?
Major companies operating in the transcatheter mitral valve market are focusing on developing advanced products, such as transcatheter mitral valve replacement systems, to broaden treatment options for high-risk or inoperable patients. Transcatheter mitral valve replacement (TMVR) systems are defined as minimally invasive medical devices that substitute a damaged or diseased mitral valve in the heart with an artificial valve through a catheter-based approach, thus eliminating the need for open-heart surgery. For instance, in May 2025, Abbott Laboratories, a US-based medical device company, launched Tendyne, which had obtained approval from the Food and Drug Administration (FDA). It is a self-expanding, nitinol-framed valve available in multiple sizes to suit varied anatomies and can be fully repositioned or retrieved during implantation. Delivered through a small incision in the chest, the system enables a minimally invasive procedure typically completed in about 1.5 hours. Designed for faster recovery, the system allows most patients to be discharged within three days, offering a transformative solution for high-risk mitral valve patients who lack viable surgical alternatives.
Which Firms Are Contributing To The Transcatheter Mitral Valve Market Ecosystem?
Major companies operating in the transcatheter mitral valve market are Abbott Laboratories, Medtronic Inc, Boston Scientific Corporation, Edwards Lifesciences Corporation, Meril Life Sciences Private Limited, MicroPort Scientific Corporation, Venus Medtech Inc., Cardiac Dimensions Inc., JenaValve Technology Inc., Ancora Heart Inc, Peijia Medical Limited, Micro Interventional Devices Inc., 4C Medical Technologies Inc., NeoChord Inc., Xeltis AG, Valcare Medical Inc., Colibri Heart Valve LLC, MitrAssist Ltd., HighLife SAS, Navigate Cardiac Structures Inc., Cardiovalve Ltd.
Get The Full Transcatheter Mitral Valve Market Report:
https://www.thebusinessresearchcompany.com/report/transcatheter-mitral-valve-global-market-report
Which Region Is The Leading Market For The Transcatheter Mitral Valve Market?
North America was the largest region in the transcatheter mitral valve market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transcatheter mitral valve market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Transcatheter Mitral Valve Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/transcatheter-mitral-valve-global-market-report
Browse Through More Reports Similar to the Global Transcatheter Mitral Valve Market 2026, By The Business Research Company
Titanium Market Report 2026
https://www.thebusinessresearchcompany.com/report/titanium-global-market-report
Carbon Nanomaterials Market Report 2026
https://www.thebusinessresearchcompany.com/report/carbon-nanomaterials-global-market-report
Aerospace Titanium Market Report 2026
https://www.thebusinessresearchcompany.com/report/aerospace-titanium-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model